Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• WBR0789  + (History of pelvic inflammatory disease)
• WBR0005  + (Hodgkin's lymphoma)
• WBR0841  + (Holter monitoring)
• WBR0779  + (Horn cysts)
• WBR0548  + (Horse fly)
• WBR0508  + (Host antibodies against donor IgA molecules)
• WBR1025  + (Hydrochlorothiazid)
• WBR0079  + (Hydrochlorothiazid)
• WBR0648  + (Hydrolysis of conjugated bilirubin)
• WBR0649  + (Hydrolysis of conjugated bilirubin)
• WBR0637  + (Hyperacetylated Rb protein)
• WBR0562  + (Hyperaldosteronism)
• WBR0778  + (Hyperkeratosis and acanthosis)
• WBR0567  + (Hyperplasia)
• WBR1079  + (Hypertension)
• WBR1013  + (Hyperthyroidism)
• WBR1141  + (Hyperthyroidism)
• WBR0021  + (Hypertrophic cardiomyopathy)
• WBR1066  + (Hypoglycemia)
• WBR0198  + (Hypomagnesemia)
• WBR0853  + (I.V Ciprofloxacin for 4-6 weeks)
• WBR0962  + (I.V glucocorticoids)
• WBR0680  + (IL-10)
• WBR0141  + (IL-8)
• WBR1090  + (IV glucagon)
• WBR0378  + (IV normal saline)

• WBR0019  + (Idiopathic)
• WBR0030  + (Idiopathic)

• WBR0874  + (Idiopathic pulmonary fibrosis)
• WBR0872  + (IgA deposits)
• WBR0476  + (IgE antibodies against hemidesmosomes)
• WBR1044  + (IgM Antibodies to dermal epidermal junction)
• WBR0828  + (Immediately administer a bolus of 15 grams of 50% dextrose)
• WBR291  + (Immotile on wet mount)
• WBR0703  + (Immune complexes)
• WBR0374  + (Immune modulation by interleukin-2 recombinant therapy)
• WBR0218  + (Imprinting)
• WBR0436  + (Imprinting)
• WBR0328  + (Inability to swallow)
• WBR0054  + (Inactivation of elongation factor-2)
• WBR284  + (Inadequate migration of neural crest cells)
• WBR1055  + (Increase albuterol dose)
• WBR0615  + (Increase in acetylcholine)
• WBR0580  + (Increase in arterial pCO2 and decrease in arterial pO2)
• WBR0949  + (Increase in carbon monoxide (CO))
• WBR0192  + (Increase in hospitalizations and no effect on overall mortality)
• WBR0732  + (Increase in insulin sensitivity)
• WBR0860  + (Increase in proton gradient across electron transport chain)
• WBR0055  + (Increase of cAMP by intrinsic enzymatic activity)
• WBR0369  + (Increased norepinephrine, Decreased GABA, Decreased serotonin)
• WBR0864  + (Increased residual volume)
• WBR0877  + (Increased urinary NGAL (neutrophil gelatinase-associated lipocalin))